A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.
A new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback